Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Algos and Interneuron codevelop novel antimigraine combination

Dec. 23, 1996

Northwest Neurologic and Wyeth-Ayerst neurodegenerative disorder collaboration

Dec. 23, 1996

Regeneron claims novel use for neurotrophic factor

Dec. 23, 1996

IND filed for chirally pure ADHD treatment

Dec. 20, 1996

Spray formulation of antimigraine Rx cleared for marketing

Dec. 20, 1996

Medtronic and Orphan Medical to develop intrathecal clonidine

Dec. 19, 1996

New insights into migraine pathology

Dec. 19, 1996

NK1 receptor antagonist synthesized by RPR

Dec. 19, 1996

DuPont Merck developing atypical antipsychotic

Dec. 19, 1996

Innapharma reports novel antidepressant

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.